November 05, 2009
IMS Health to be sold for $5.2 billion
by Matthew Dennis
IMS Health announced Thursday that it agreed to be acquired by investment funds TPG Capital and CPP Investment Board in a deal valued at $5.2 billion. IMS CEO David Carlucci said the sale of the company, which is expected to close in the first quarter of 2010, would allow it to “continue [its] focus on expanding into new markets” and assume “a bigger role in the healthcare market.”
The company said the deal, under which shareholders will receive $22.00 per share, represents a premium of around 50 percent over the closing price on October 16, when speculation surfaced that the company may be put up for sale. The healthcare data company noted in a statement that the offer price includes the assumption of debt, which IMS reported last month stood at $1.34 billion as of September 30.
Charles Bobrinskoy, vice chairman at Ariel Investments, which is IMS’ largest shareholder, said the investment fund “would strongly support a transaction at the price being discussed.” 
Reference Articles
|